RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 49.72 Million | 17.5 Million | 27.76 Million | 240.03 Million | 263.7 Million | 245.74 Million |
| Cost of Revenue | 9.45 Million | 3.61 Million | 3.29 Million | 111.63 Million | 141.95 Million | 126.27 Million |
| Gross Profit | 40.26 Million | 13.88 Million | 24.46 Million | 128.4 Million | 121.74 Million | 119.46 Million |
| Operating Expenses | 85.94 Million | 94.39 Million | 86.21 Million | 125.34 Million | 116.06 Million | 98.55 Million |
| Selling, General and Administrative Expenses | 81.97 Million | 87.46 Million | 72.82 Million | 93.03 Million | 72.36 Million | 55.86 Million |
| Research and Development Expenses | 3.96 Million | 6.93 Million | 13.38 Million | 32.31 Million | 43.69 Million | 42.68 Million |
| Other Expenses | 13.31 Million | -1.33 Million | -48 Thousand | 884 Thousand | - | - |
| Cost and Expenses | 108.71 Million | 98.01 Million | 89.5 Million | 236.97 Million | 258.01 Million | 224.83 Million |
| Operating Income | -58.99 Million | -82.75 Million | -90.65 Million | -280.69 Million | 5.68 Million | 20.91 Million |
| Interest Expense | 3.11 Million | 4.01 Million | 4.09 Million | 18.21 Million | 20.79 Million | 29.05 Million |
| Income Tax Expense | -20 Thousand | 315 Thousand | -5.78 Million | -27.12 Million | -8.98 Million | -44.5 Million |
| Earnings before Tax | -51.71 Million | -82.53 Million | -94.79 Million | -298.02 Million | -118.66 Million | -85.64 Million |
| Net Income | -51.69 Million | -64.92 Million | -79.58 Million | -270.9 Million | -109.68 Million | -41.14 Million |
| Earnings Per Share Basic | -0.58 | -0.96 | -1.31 | -5.17 | -2.42 | -0.96 |
| Earnings Per Share Diluted | -0.58 | -0.96 | -1.31 | -5.17 | -2.42 | -0.96 |
| Weighted Average Shares Outstanding | 89.79 Million | 67.35 Million | 60.65 Million | 52.36 Million | 45.27 Million | 42.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.79 Million | 67.35 Million | 60.65 Million | 52.36 Million | 45.27 Million | 42.85 Million |
| Gross Margin | 0.81 | 0.79 | 0.88 | 0.53 | 0.46 | 0.49 |
| EBIT Margin | -0.97 | -4.21 | -1.47 | 0.25 | 0.33 | 0.27 |
| Profit Margin | -1.04 | -3.71 | -2.87 | -1.13 | -0.42 | -0.17 |
| EBITDA | -48.22 Million | -70.34 Million | -69.67 Million | -222.79 Million | -16.27 Million | -10.14 Million |
| Earnings Before Tax Margin | -1.19 | -4.73 | -3.27 | -1.17 | 0.02 | 0.09 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.25 Million | 8.83 Million | 9.8 Million | 49.72 Million | 10.02 Million | 8.44 Million |
| Cost of Revenue | 1.94 Million | 2.29 Million | 2.56 Million | 9.45 Million | 2.6 Million | 2.3 Million |
| Gross Profit | 6.31 Million | 6.53 Million | 7.24 Million | 40.26 Million | 7.41 Million | 6.14 Million |
| Operating Expenses | 14.43 Million | 16.82 Million | 18.48 Million | 85.94 Million | 21.33 Million | 21.26 Million |
| Selling, General and Administrative Expenses | 13.88 Million | 16.19 Million | 17.6 Million | - | 20.29 Million | 20.09 Million |
| Research and Development Expenses | 547 Thousand | 626 Thousand | 884 Thousand | - | 1.04 Million | 1.17 Million |
| Other Expenses | 371 Thousand | 5.43 Million | 884 Thousand | 6.26 Million | - | - |
| Cost and Expenses | 16.37 Million | 19.12 Million | 21.04 Million | 95.4 Million | 23.94 Million | 23.57 Million |
| Operating Income | -22.02 Million | -10.29 Million | -24.54 Million | -58.99 Million | -13.92 Million | -15.12 Million |
| Interest Expense | 3.15 Million | 7.37 Million | 4.77 Million | 3.11 Million | 1.13 Million | 978 Thousand |
| Income Tax Expense | -113 Thousand | 58 Thousand | -285 Thousand | -20 Thousand | 63 Thousand | 277 Thousand |
| Earnings before Tax | -24 Million | -11.55 Million | -18.6 Million | -51.71 Million | -14.38 Million | -11.82 Million |
| Net Income | -23.88 Million | -11.61 Million | -18.31 Million | -51.69 Million | -14.44 Million | -12.1 Million |
| Earnings Per Share Basic | -0.24 | -0.12 | -0.18 | - | -0.16 | -0.14 |
| Earnings Per Share Diluted | -0.24 | -0.12 | -0.18 | - | -0.16 | -0.14 |
| Weighted Average Shares Outstanding | 99.37 Million | 99.32 Million | 99.15 Million | 89.79 Million | 92.75 Million | 83.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.37 Million | 99.32 Million | 99.15 Million | 89.79 Million | 92.75 Million | 83.58 Million |
| Gross Margin | 0.76 | 0.74 | 0.74 | 0.81 | 0.74 | 0.73 |
| EBIT Margin | -0.93 | -0.54 | -0.75 | - | -1.38 | -1.78 |
| Profit Margin | -2.89 | -1.31 | -1.87 | -1.04 | -1.44 | -1.43 |
| EBITDA | -7.65 Million | -4.76 Million | -7.39 Million | - | -13.82 Million | -15.03 Million |
| Earnings Before Tax Margin | -2.67 | -1.17 | -2.50 | -1.19 | -1.39 | -1.79 |
CEM
1U1
ENVIP
3301
SHBI
USM